世界のパーキンソン病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Parkinson’s Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4659
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、124ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、パーキンソン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、経皮、皮下、腸内注入）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・パーキンソン病治療の市場動向
・企業の競争状況、市場シェア
・パーキンソン病治療の種類別市場規模と予測2016-2027（経口、経皮、皮下、腸内注入）
・パーキンソン病治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・パーキンソン病治療の北米市場規模2016-2027（アメリカ、カナダ）
・パーキンソン病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・パーキンソン病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・パーキンソン病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・パーキンソン病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Teva、Roche、Prothena、Acorda Therapeutics、Voyager Therapeutics、Impax Pharmaceuticals、UCB、AbbVie、MSD、Orion Pharmaceuticals、Intec Pharma、NeuroDerm、Adamas Therapeutics、Acadia、Sunovion、GSK）
・結論

Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.

Market Analysis and Insights: Global Parkinson’s Disease Treatment Market
The global Parkinson’s Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson’s Disease Treatment market.

Global Parkinson’s Disease Treatment Scope and Market Size
Parkinson’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Roche
Prothena
Acorda Therapeutics
Voyager Therapeutics
Impax Pharmaceuticals
UCB
AbbVie
MSD
Orion Pharmaceuticals
Intec Pharma
NeuroDerm
Adamas Therapeutics
Acadia
Sunovion
GSK

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Transdermal
1.2.4 Subcutaneous
1.2.5 Intestinal Infusion
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Parkinson’s Disease Treatment Market Perspective (2016-2027)
2.2 Parkinson’s Disease Treatment Growth Trends by Regions
2.2.1 Parkinson’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson’s Disease Treatment Industry Dynamic
2.3.1 Parkinson’s Disease Treatment Market Trends
2.3.2 Parkinson’s Disease Treatment Market Drivers
2.3.3 Parkinson’s Disease Treatment Market Challenges
2.3.4 Parkinson’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Treatment Players by Revenue
3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson’s Disease Treatment Revenue
3.4 Global Parkinson’s Disease Treatment Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2020
3.5 Parkinson’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Parkinson’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Parkinson’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson’s Disease Treatment Breakdown Data by Type
4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Parkinson’s Disease Treatment Breakdown Data by Application
5.1 Global Parkinson’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Parkinson’s Disease Treatment Market Size (2016-2027)
6.2 North America Parkinson’s Disease Treatment Market Size by Type
6.2.1 North America Parkinson’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Parkinson’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Parkinson’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Parkinson’s Disease Treatment Market Size by Application
6.3.1 North America Parkinson’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Parkinson’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Parkinson’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Parkinson’s Disease Treatment Market Size by Country
6.4.1 North America Parkinson’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Parkinson’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Parkinson’s Disease Treatment Market Size (2016-2027)
7.2 Europe Parkinson’s Disease Treatment Market Size by Type
7.2.1 Europe Parkinson’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Parkinson’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Parkinson’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Parkinson’s Disease Treatment Market Size by Application
7.3.1 Europe Parkinson’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Parkinson’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Parkinson’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Parkinson’s Disease Treatment Market Size by Country
7.4.1 Europe Parkinson’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Parkinson’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Parkinson’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Parkinson’s Disease Treatment Market Size by Type
9.2.1 Latin America Parkinson’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Parkinson’s Disease Treatment Market Size by Application
9.3.1 Latin America Parkinson’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Parkinson’s Disease Treatment Market Size by Country
9.4.1 Latin America Parkinson’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Parkinson’s Disease Treatment Introduction
11.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Parkinson’s Disease Treatment Introduction
11.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Prothena
11.3.1 Prothena Company Details
11.3.2 Prothena Business Overview
11.3.3 Prothena Parkinson’s Disease Treatment Introduction
11.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.3.5 Prothena Recent Development
11.4 Acorda Therapeutics
11.4.1 Acorda Therapeutics Company Details
11.4.2 Acorda Therapeutics Business Overview
11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction
11.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.4.5 Acorda Therapeutics Recent Development
11.5 Voyager Therapeutics
11.5.1 Voyager Therapeutics Company Details
11.5.2 Voyager Therapeutics Business Overview
11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction
11.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.5.5 Voyager Therapeutics Recent Development
11.6 Impax Pharmaceuticals
11.6.1 Impax Pharmaceuticals Company Details
11.6.2 Impax Pharmaceuticals Business Overview
11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction
11.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.6.5 Impax Pharmaceuticals Recent Development
11.7 UCB
11.7.1 UCB Company Details
11.7.2 UCB Business Overview
11.7.3 UCB Parkinson’s Disease Treatment Introduction
11.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.7.5 UCB Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Parkinson’s Disease Treatment Introduction
11.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 MSD
11.9.1 MSD Company Details
11.9.2 MSD Business Overview
11.9.3 MSD Parkinson’s Disease Treatment Introduction
11.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.9.5 MSD Recent Development
11.10 Orion Pharmaceuticals
11.10.1 Orion Pharmaceuticals Company Details
11.10.2 Orion Pharmaceuticals Business Overview
11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction
11.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.10.5 Orion Pharmaceuticals Recent Development
11.11 Intec Pharma
11.11.1 Intec Pharma Company Details
11.11.2 Intec Pharma Business Overview
11.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction
11.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.11.5 Intec Pharma Recent Development
11.12 NeuroDerm
11.12.1 NeuroDerm Company Details
11.12.2 NeuroDerm Business Overview
11.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction
11.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.12.5 NeuroDerm Recent Development
11.13 Adamas Therapeutics
11.13.1 Adamas Therapeutics Company Details
11.13.2 Adamas Therapeutics Business Overview
11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction
11.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.13.5 Adamas Therapeutics Recent Development
11.14 Acadia
11.14.1 Acadia Company Details
11.14.2 Acadia Business Overview
11.14.3 Acadia Parkinson’s Disease Treatment Introduction
11.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.14.5 Acadia Recent Development
11.15 Sunovion
11.15.1 Sunovion Company Details
11.15.2 Sunovion Business Overview
11.15.3 Sunovion Parkinson’s Disease Treatment Introduction
11.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.15.5 Sunovion Recent Development
11.16 GSK
11.16.1 GSK Company Details
11.16.2 GSK Business Overview
11.16.3 GSK Parkinson’s Disease Treatment Introduction
11.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2016-2021)
11.16.5 GSK Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Transdermal
Table 4. Key Players of Subcutaneous
Table 5. Key Players of Intestinal Infusion
Table 6. Global Parkinson’s Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Parkinson’s Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Parkinson’s Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Parkinson’s Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Parkinson’s Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Parkinson’s Disease Treatment Market Share by Regions (2022-2027)
Table 12. Parkinson’s Disease Treatment Market Trends
Table 13. Parkinson’s Disease Treatment Market Drivers
Table 14. Parkinson’s Disease Treatment Market Challenges
Table 15. Parkinson’s Disease Treatment Market Restraints
Table 16. Global Parkinson’s Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Parkinson’s Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson’s Disease Treatment as of 2020)
Table 19. Ranking of Global Top Parkinson’s Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Parkinson’s Disease Treatment Product Solution and Service
Table 23. Date of Enter into Parkinson’s Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Parkinson’s Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Teva Company Details
Table 64. Teva Business Overview
Table 65. Teva Parkinson’s Disease Treatment Product
Table 66. Teva Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Teva Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Parkinson’s Disease Treatment Product
Table 71. Roche Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Prothena Company Details
Table 74. Prothena Business Overview
Table 75. Prothena Parkinson’s Disease Treatment Product
Table 76. Prothena Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Prothena Recent Development
Table 78. Acorda Therapeutics Company Details
Table 79. Acorda Therapeutics Business Overview
Table 80. Acorda Therapeutics Parkinson’s Disease Treatment Product
Table 81. Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. Acorda Therapeutics Recent Development
Table 83. Voyager Therapeutics Company Details
Table 84. Voyager Therapeutics Business Overview
Table 85. Voyager Therapeutics Parkinson’s Disease Treatment Product
Table 86. Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Voyager Therapeutics Recent Development
Table 88. Impax Pharmaceuticals Company Details
Table 89. Impax Pharmaceuticals Business Overview
Table 90. Impax Pharmaceuticals Parkinson’s Disease Treatment Product
Table 91. Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Impax Pharmaceuticals Recent Development
Table 93. UCB Company Details
Table 94. UCB Business Overview
Table 95. UCB Parkinson’s Disease Treatment Product
Table 96. UCB Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. UCB Recent Development
Table 98. AbbVie Company Details
Table 99. AbbVie Business Overview
Table 100. AbbVie Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. AbbVie Recent Development
Table 102. MSD Company Details
Table 103. MSD Business Overview
Table 104. MSD Parkinson’s Disease Treatment Product
Table 105. MSD Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. MSD Recent Development
Table 107. Orion Pharmaceuticals Company Details
Table 108. Orion Pharmaceuticals Business Overview
Table 109. Orion Pharmaceuticals Parkinson’s Disease Treatment Product
Table 110. Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 111. Orion Pharmaceuticals Recent Development
Table 112. Intec Pharma Company Details
Table 113. Intec Pharma Business Overview
Table 114. Intec Pharma Parkinson’s Disease Treatment Product
Table 115. Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 116. Intec Pharma Recent Development
Table 117. NeuroDerm Company Details
Table 118. NeuroDerm Business Overview
Table 119. NeuroDerm Parkinson’s Disease Treatment Product
Table 120. NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 121. NeuroDerm Recent Development
Table 122. Adamas Therapeutics Company Details
Table 123. Adamas Therapeutics Business Overview
Table 124. Adamas Therapeutics Parkinson’s Disease Treatment Product
Table 125. Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 126. Adamas Therapeutics Recent Development
Table 127. Acadia Company Details
Table 128. Acadia Business Overview
Table 129. Acadia Parkinson’s Disease Treatment Product
Table 130. Acadia Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 131. Acadia Recent Development
Table 132. Sunovion Company Details
Table 133. Sunovion Business Overview
Table 134. Sunovion Parkinson’s Disease Treatment Product
Table 135. Sunovion Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 136. Sunovion Recent Development
Table 137. GSK Company Details
Table 138. GSK Business Overview
Table 139. GSK Parkinson’s Disease Treatment Product
Table 140. GSK Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 141. GSK Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson’s Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Transdermal Features
Figure 4. Subcutaneous Features
Figure 5. Intestinal Infusion Features
Figure 6. Global Parkinson’s Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Parkinson’s Disease Treatment Report Years Considered
Figure 11. Global Parkinson’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Parkinson’s Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Parkinson’s Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Parkinson’s Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Parkinson’s Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson’s Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Parkinson’s Disease Treatment Revenue in 2020
Figure 18. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Parkinson’s Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Parkinson’s Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Parkinson’s Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Parkinson’s Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Parkinson’s Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Parkinson’s Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Parkinson’s Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Parkinson’s Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Parkinson’s Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Parkinson’s Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Parkinson’s Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Parkinson’s Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Parkinson’s Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Parkinson’s Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Parkinson’s Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 61. Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 62. Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 63. Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 64. Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 65. UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 67. MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 68. Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 69. Intec Pharma Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 70. NeuroDerm Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 71. Adamas Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 72. Acadia Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 73. Sunovion Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 74. GSK Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のパーキンソン病における脳深部刺激療法市場規模・現状・予測（2021年-2027年）

Global Deep Brain Stimulation in Parkinson's Disease Market Size, Status and Forecast 2021-2027
QFJ1-4100 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、パーキンソン病における脳深部刺激療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デュアルチャネル脳深部刺激装置、シングルチャネル脳深部刺激装置）、用途別市場規模（病院、神経科クリニック、研究センタ...

世界のファブリー病治療市場規模・現状・予測（2021年-2027年）

Global Fabry Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4214 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、ファブリー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法（ERT）、シャペロン治療、基質減少療法（SRT）、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北...

世界のスティル病治療市場規模・現状・予測（2021年-2027年）

Global Still’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4906 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、スティル病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、トシリズマブ、カナキヌマブ、アナキンラ、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場...

世界の網膜疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4825 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、ア...

世界の神経変性疾患治療市場規模・現状・予測（2021年-2027年）

Global Neurodegenerative Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4565 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、神経変性疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（神経伝達物質、神経保護剤、生物製剤、その他）、用途別市場規模（多発性硬化症[MS]、アルツハイマー病、パーキンソン病、急性片頭痛、自閉症...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Pediatric Respiratory Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4675 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児呼吸器疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、気管支拡張薬、併用薬、コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（喘息、嚢胞性線維症、細気管支炎、肺...

世界の関節疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Joint Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4400 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、関節疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、リハビリテーション、外科手術）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のアルツハイマー病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer Disease Treatment Market The global Alzheimer Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界のパーキンソン病における脳深部刺激療法市場規模・現状・予測（2021年-2027年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some o…
世界の小売薬局市場規模・現状・予測（2021年-2027年） A retail pharmacy refers to a retail store of medicines. Market Analysis and Insights: Global Retail Pharmacy Market The global Retail Pharmacy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in…
世界のグリコーゲン代謝＆糖原病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market The global Glycogen Metabolism and Glycogen Storage Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With …
世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …